Quantum X Labs Statistics
Total Valuation
Quantum X Labs has a market cap or net worth of $113.66 million. The enterprise value is $113.13 million.
| Market Cap | 113.66M |
| Enterprise Value | 113.13M |
Important Dates
The next estimated earnings date is Friday, November 13, 2026, before market open.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Quantum X Labs has 21.57 million shares outstanding. The number of shares has increased by 103.95% in one year.
| Current Share Class | 21.57M |
| Shares Outstanding | 21.57M |
| Shares Change (YoY) | +103.95% |
| Shares Change (QoQ) | +74.56% |
| Owned by Insiders (%) | 7.10% |
| Owned by Institutions (%) | 2.10% |
| Float | 14.01M |
Valuation Ratios
The trailing PE ratio is 94.34.
| PE Ratio | 94.34 |
| Forward PE | n/a |
| PS Ratio | 86.37 |
| Forward PS | n/a |
| PB Ratio | 3.85 |
| P/TBV Ratio | 41.14 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 85.97 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.86, with a Debt / Equity ratio of 0.07.
| Current Ratio | 0.86 |
| Quick Ratio | 0.75 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -0.03% and return on invested capital (ROIC) is -12.86%.
| Return on Equity (ROE) | -0.03% |
| Return on Assets (ROA) | -7.44% |
| Return on Invested Capital (ROIC) | -12.86% |
| Return on Capital Employed (ROCE) | -11.25% |
| Weighted Average Cost of Capital (WACC) | 17.02% |
| Revenue Per Employee | $62,667 |
| Profits Per Employee | -$99,000 |
| Employee Count | 21 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -124,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +88.89% in the last 52 weeks. The beta is 2.37, so Quantum X Labs's price volatility has been higher than the market average.
| Beta (5Y) | 2.37 |
| 52-Week Price Change | +88.89% |
| 50-Day Moving Average | 4.74 |
| 200-Day Moving Average | 3.23 |
| Relative Strength Index (RSI) | 57.59 |
| Average Volume (20 Days) | 70,537 |
Short Selling Information
The latest short interest is 69,368, so 0.32% of the outstanding shares have been sold short.
| Short Interest | 69,368 |
| Short Previous Month | 86,467 |
| Short % of Shares Out | 0.32% |
| Short % of Float | 0.50% |
| Short Ratio (days to cover) | 1.54 |
Income Statement
In the last 12 months, Quantum X Labs had revenue of $1.32 million and -$2.08 million in losses. Loss per share was -$0.18.
| Revenue | 1.32M |
| Gross Profit | 937,000 |
| Operating Income | -3.05M |
| Pretax Income | -129,000 |
| Net Income | -2.08M |
| EBITDA | -2.70M |
| EBIT | -3.05M |
| Loss Per Share | -$0.18 |
Balance Sheet
The company has $2.44 million in cash and $1.91 million in debt, with a net cash position of $530,000 or $0.02 per share.
| Cash & Cash Equivalents | 2.44M |
| Total Debt | 1.91M |
| Net Cash | 530,000 |
| Net Cash Per Share | $0.02 |
| Equity (Book Value) | 25.78M |
| Book Value Per Share | 1.37 |
| Working Capital | -550,000 |
Cash Flow
In the last 12 months, operating cash flow was -$4.29 million and capital expenditures -$186,000, giving a free cash flow of -$4.48 million.
| Operating Cash Flow | -4.29M |
| Capital Expenditures | -186,000 |
| Depreciation & Amortization | 352,000 |
| Net Borrowing | -3.35M |
| Free Cash Flow | -4.48M |
| FCF Per Share | -$0.21 |
Margins
Gross margin is 71.20%, with operating and profit margins of -231.84% and -157.98%.
| Gross Margin | 71.20% |
| Operating Margin | -231.84% |
| Pretax Margin | -9.80% |
| Profit Margin | -157.98% |
| EBITDA Margin | -205.09% |
| EBIT Margin | -231.84% |
| FCF Margin | n/a |
Dividends & Yields
Quantum X Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -103.95% |
| Shareholder Yield | -103.95% |
| Earnings Yield | -1.83% |
| FCF Yield | -3.94% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 14, 2025. It was a reverse split with a ratio of 1:4.
| Last Split Date | Mar 14, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
Quantum X Labs has an Altman Z-Score of 1.33 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.33 |
| Piotroski F-Score | 2 |